Involvement of microRNAs in dioxin-induced liver damage in the mouse

Wataru Yoshioka1, Wataru Higashiyama, Chiharu Tohyama

  • 1Laboratory of Environmental Health Sciences, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.

Insights

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure downregulates microRNA-101a (miR-101a) and microRNA-122 (miR-122) in mice. Upregulated cyclooxygenase-2 (COX-2), a miR-101a target, contributes to TCDD-induced liver damage.

Area of Science:

  • Toxicology
  • Molecular Biology
  • Gene Regulation

Background:

  • MicroRNAs (miRNAs) are small RNAs regulating gene expression, with largely unknown roles in disease.
  • Xenobiotic chemicals can disrupt cellular pathways, but their impact on miRNA expression and toxicity is under-investigated.
  • 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a potent environmental toxicant known to cause various adverse effects.

Purpose of the Study:

  • To investigate the role of miRNAs in the toxic responses to xenobiotic chemicals, specifically TCDD.
  • To identify specific miRNAs and their target genes involved in TCDD-induced liver damage in mice.
  • To elucidate the mechanism by which TCDD-induced miRNA dysregulation contributes to hepatotoxicity.

Main Methods:

  • Mice were exposed to TCDD, and miRNA expression levels (miR-101a, miR-122) were quantified over time.
  • Target genes of downregulated miRNAs, including cyclooxygenase-2 (COX-2), were identified and their expression levels measured.
  • The effect of a COX-2 selective inhibitor (NS-398) on TCDD-induced liver damage was assessed.

Main Results:

  • TCDD exposure led to a time-dependent downregulation of miR-101a and miR-122 in mouse liver.
  • Target genes of miR-101a, such as COX-2, were significantly upregulated, indicating miRNA-mediated repression.
  • Inhibition of COX-2 activity with NS-398 ameliorated TCDD-induced liver damage, implicating COX-2 in the toxic pathway.

Conclusions:

  • TCDD dysregulates the expression of specific miRNAs, including miR-101a and miR-122, in the mouse liver.
  • The upregulation of COX-2, a target gene of miR-101a, is a key mechanism contributing to TCDD-induced hepatotoxicity.
  • Targeting miR-101a-regulated pathways, such as COX-2, may offer therapeutic strategies for TCDD toxicity.